Literature DB >> 11574621

Performance of candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida.

B Willinger1, C Hillowoth, B Selitsch, M Manafi.   

Abstract

Candida ID agar allows identification of Candida albicans and differentiation of other Candida species. In comparison with CHROMagar Candida, we evaluated the performance of this medium directly from 596 clinical specimens. In particular, detection of C. albicans after 24 h of incubation was easier on Candida ID (sensitivity, 96.8%) than on CHROMagar (sensitivity, 49.6%).

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11574621      PMCID： PMC88437          DOI： 10.1128/JCM.39.10.3793-3795.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

Review 1.  Yeast identification in the clinical microbiology laboratory: phenotypical methods.

Authors:  A M Freydiere; R Guinet; P Boiron
Journal:  Med Mycol       Date:  2001-02       Impact factor: 4.076

2.  Evaluation of phenotypic markers for selection and identification of Candida dubliniensis.

Authors:  K Tintelnot; G Haase; M Seibold; F Bergmann; M Staemmler; T Franz; D Naumann
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

3.  Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species.

Authors:  B Willinger; M Manafi
Journal:  Mycoses       Date:  1999-04       Impact factor: 4.377

4.  Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata.

Authors:  M A Pfaller; A Houston; S Coffmann
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 5.  Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review.

Authors:  E Anaissie
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

6.  Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species.

Authors:  H Fricker-Hidalgo; S Orenga; B Lebeau; H Pelloux; M P Brenier-Pinchart; P Ambroise-Thomas; R Grillot
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

7.  Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance.

Authors:  S Bernal; E Martín Mazuelos; M García; A I Aller; M A Martínez; M J Gutiérrez
Journal:  Diagn Microbiol Infect Dis       Date:  1996-04       Impact factor: 2.803

8.  CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.

Authors:  F C Odds; R Bernaerts
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948
  8 in total
  18 in total

Review 1.  A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.

Authors:  John D Perry
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

2.  Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis.

Authors:  A Borst; B Theelen; E Reinders; T Boekhout; A C Fluit; P H M Savelkoul
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Microsatellite marker analysis as a typing system for Candida glabrata.

Authors:  F Foulet; N Nicolas; O Eloy; F Botterel; J-C Gantier; J-M Costa; S Bretagne
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  An evaluation of risk factors in pregnant women with Candida vaginitis and the diagnostic value of simultaneous vaginal and rectal sampling.

Authors:  Ahmet Barış Guzel; Macit Ilkit; Refik Burgut; Ibrahim Ferhat Urunsak; Fatma Tuncay Ozgunen
Journal:  Mycopathologia       Date:  2011-02-04       Impact factor: 2.574

5.  Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species.

Authors:  Elena Eraso; María D Moragues; María Villar-Vidal; Ismail H Sahand; Nagore González-Gómez; José Pontón; Guillermo Quindós
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

6.  Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories.

Authors:  A M Freydiere; J D Perry; O Faure; B Willinger; A M Tortorano; A Nicholson; J Peman; P E Verweij
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 7.  [Diagnosing fungal infections: trends and new developments].

Authors:  Birgit Willinger
Journal:  Wien Med Wochenschr       Date:  2007

8.  Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories.

Authors:  M A Piens; J D Perry; H Raberin; F Parant; A M Freydière
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

9.  In vitro evaluation of putative virulence attributes of oral isolates of Candida spp. obtained from elderly healthy individuals.

Authors:  Luciana Furlaneto-Maia; Ana Flavia Specian; Fernando Cesar Bizerra; Marcelo Tempesta de Oliveira; Márcia Cristina Furlaneto
Journal:  Mycopathologia       Date:  2008-07-03       Impact factor: 2.574

10.  Identification of Candida glabrata by a 30-second trehalase test.

Authors:  A-M Freydière; F Parant; F Noel-Baron; M Crepy; A Treny; H Raberin; A Davidson; F C Odds
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.